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Abstract
DNA methylation is essential in X chromosome inactivation and genomic imprinting, maintaining repression of XIST in the
active X chromosome and monoallelic repression of imprinted genes. Disruption of the DNA methyltransferase genes DNMT1
and DNMT3B in the HCT116 cell line (DKO cells) leads to global DNA hypomethylation and biallelic expression of the imprinted
gene IGF2 but does not lead to reactivation of XIST expression, suggesting that XIST repression is due to a more stable
epigenetic mark than imprinting. To test this hypothesis, we induced acute hypomethylation in HCT116 cells by 5-aza-29-
deoxycytidine (5-aza-CdR) treatment (HCT116-5-aza-CdR) and compared that to DKO cells, evaluating DNA methylation by
microarray and monitoring the expression of XIST and imprinted genes IGF2, H19, and PEG10. Whereas imprinted genes
showed biallelic expression in HCT116-5-aza-CdR and DKO cells, the XIST locus was hypomethylated and weakly expressed
only under acute hypomethylation conditions, indicating the importance of XIST repression in the active X to cell survival. Given
that DNMT3A is the only active DNMT in DKO cells, it may be responsible for ensuring the repression of XIST in those cells.
Taken together, our data suggest that XIST repression is more tightly controlled than genomic imprinting and, at least in part, is
due to DNMT3A.
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Introduction
Two striking epigenetic phenomena in mammalians are
X chromosome inactivation (XCI) and genomic imprinting.
XCI triggers the transcriptional silencing of most genes in all
but one X chromosome in females (1), while genomic
imprinting is a process that leads to monoallelic gene
expression based on parental origin (2). DNAmethylation, a
covalent modification catalyzed by DNAmethyltransferases
(DNMTs) (3), is a key player of XCI and genomic imprinting.
This and other epigenetic marks, such as histone modifica-
tions (4), are responsible for gene silencing in the inactive X
chromosome and maintenance of XIST repression in the
active X chromosome (5-8), and the monoallelic repression
of imprinted genes is ensured by DNA methylation at
either imprinting center regions (ICRs) or other cytosine-
phosphate-guanine (CpG) controlling regions (9-12).
In the human male cancer cell line HCT116, disruption
of the DNMT1 and DNMT3B genes leads to global DNA
hypomethylation and biallelic expression of the imprinted
gene IGF2 (13). In contrast, XIST repression is maintained
when there is a decrease in DNMT1 and DNMT3B activity
(14), suggesting that XIST repression is more tightly
controlled than the allele-specific expression of imprinted
genes. It has been shown that ectopic expression of XIST
leads to inactivation of the transgene-containing autosome
in male human cells (15). Thus, expression of XIST in a
46,XY cell may be detrimental, since it might silence the
only X chromosome present in the cell. Therefore, lack of
XIST expression in the DKO cell line could be due to
selection during the relatively long process of knocking out
the DNMT1 and DNMT3B genes in HCT116 cells.
With the aim to test this hypothesis, we acutely induced
DNA hypomethylation in parental HCT116 cells using 5-
aza-29-deoxycytidine (5-aza-CdR) and investigated the
DNAmethylation profile of the XIST locus and all imprinted
genes described so far, as well as the expression of XIST
and the three imprinted genes IGF2, H19, and PEG10.
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Material and Methods
Cell culture
The parental and double-knockout of DNMT1 and
DNMT3B (DKO) HCT116 cell lines were kindly provided
by Drs. B. Vogelstein and K. Schuebel (13). Cells were
cultured in McCoy media supplemented with 10% fetal calf
serum and penicillin-streptomycin (Invitrogen, USA) at
376C and 5% CO2. Cells at the mid-log phase in 100-mm
culture dishes were supplemented with fresh media
containing 0.5 to 10 mM 5-aza-CdR in order to obtain the
concentration that causes DNA hypomethylation similar to
that seen in DKO. Fresh media with 5-aza-CdR was added
every 24 h for 96 h, after which DNA and RNA were
immediately extracted. The cell culture state was mon-
itored visually throughout the treatments (Supplementary
Figure S1).
Analysis of global methylation after 5-aza-CdR
treatment
Genomic DNA (1 mg) was extracted with a FlexiGene
DNA kit (Qiagen, Germany) and digested by 1 unit ofMspI
or HpaII (FastDigest, Fermentas, Germany) at 376C
overnight and resolved on 1% agarose gel. The intensity
of non-digested (ND) or digested DNA bands was
quantified by the ImageJ software (National Institutes of
Health, USA). The percentage of Global DNA methylation
was estimated as follows: % Methylation = (HpaII – MspI)
?100%/ND.
Genome-wide DNA methylation profile
A total of 1 mg of genomic DNA extracted from HCT116
and HCT116 cells treated with 10 mM 5-aza-CdR was
bisulfite-converted using an EZ DNA methylation kit (Zymo
Research, USA). The bisulfite-modified DNA samples
were hybridized onto Infinium HumanMethylation450K
BeadChip (Illumina, USA) following the manufacturer’s
instructions. The level of DNA methylation of each CpG
was measured in b-values ranging from 0 to 1 [b=intensity
of the methylated allele (M)/intensity of the unmethylated
allele (U)+intensity of M+100] using the GenomeStudio
methylation module software (Illumina). DNA methylation
data from the DKO cell line using the same platform
(InfiniumHumanMethylation450K BeadChip, Illumina) were
retrieved from Gene Expression Omnibus (http://www.ncbi.
nlm.nih.gov/geo/; accession number GSE29290, sample
GSM815139).
The CpG probes related to imprinted genes, X
chromosome, and XIST were retrieved from full data of
the 450K microarrays and used for methylation analysis.
Only probes with detection values of P#0.01 and b-values
for all samples were used for subsequent analysis. The
list of human imprinted genes was built based on the
Catalogue of Imprinted Genes (http://igc.otago.ac.nz) and
Geneimprinting (www.geneimprint.com/) databases
(Supplementary Table S1). For statistical analysis, we
used the Kruskal-Wallis test at P#0.05 and Dunn’s
multiple comparison test for post hoc analysis; both were
performed using the GraphPad PRISM statistics software
package (USA).
Analysis of XIST expression
Real-time reverse transcriptase-polymerase chain
reaction (real-time RT-PCR). Total RNA was extracted
using RNeasy (Qiagen, Germany) and treated with DNase
Turbo DNA-Free (Ambion, USA) to avoid DNA contamina-
tion. One to two micrograms of total DNase-treated RNA
were reverse transcribed using the SuperScript III first-strand
synthesis system (Invitrogen, USA), and the XIST RNA level
was determined by real-timeRT-PCR (7500FASTSequence
Detection System; Applied Biosystems, USA) using the
probe XIST (ID Hs01079824_m1; Applied Biosystems).
XIST expression was normalized with the expression of
YWAHZ [forward (F): TCCTTTGCTTGCATCCCA; reverse
(R): AAGGCAGACAATGACAGACCA], described as a
stable reference in the HCT116 cell line exposed to 5-
aza-CdR (16). RNA fold expression was determined as
previously described by Livak and Schmittgen (17). Two
technical replicates of each reaction were performed.
RNA fluorescence in situ hybridization (RNA FISH).
HCT116 cells were cultured and treated with 10 mM 5-aza-
CdR for 96 h on Lab-Tek coverslips (Nunc, USA), and was
followed by the modified RNA FISH protocol that was
performed similar to that described by Chaumeil et al. (18).
The XIST probe used is a 2.5 kb XIST cDNA containing
exons 2, 3, 4, and 5, and was provided by Dr. Huntington
Figure 1. Global DNA methylation analysis. A, One percent
agarose gel staining with ethidium bromide showing non-digested
DNA (ND) and DNA digested with MspI or HpaII, which is an
isoschizomer of MspI methylation sensitive enzyme, at different
media concentrations of 5-aza-29-deoxycytidine (5-aza-CdR; 0,
0.5, 1.0, and 10 mM). B, Percentage of DNA methylation of each
5-aza-CdR treatment condition and DKO cells in relation to basal
methylation of the HCT116 cell line (data from 2 different assays).
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Willard (Case Western University, Cleveland, OH, USA).
A total of 100 nuclei were analyzed.
Analysis of imprinted genes
Single nucleotide polymorphism (SNP) selection.
Based on the National Center for Biotechnology Informa-
tion (USA) dbSNP BUILD 129 (http://www.ncbi.nlm.nih.gov/
SNP), we selected three imprinted genes that are expressed
in human colorectal tumor, encompassing 13 SNPs located
in coding regions (Supplementary Table S2). Primers for
IGF2 (F: 59-CCTAGTCGTGGCTCTCCATC-39; R: 59-TTA
AAGACAAAACCCAAGCATG-39) and H19 (F: 59-AGCC
CAACATCAAAGACACC-39; R: 59-AATGGAATGCTTGAA
GGCTG-39) were designed using Primer-Blast (http://www.
ncbi.nlm.nih.gov/tools/primer-blast/); PEG10 primers were
described in Kim et al. (19).
Genotyping and analysis of allele-specific gene
expression. DNA from HCT116 cells was extracted using
a FlexiGene DNA kit (Qiagen). An aliquot of 100 ng of DNA
was used as a template for PCR amplification of the region
encompassing each SNP, in order to select the informative
ones.
Synthesis of cDNA from HCT116, HCT116 5-aza-
CdR-treated and DKO cells was performed as described
above and used as templates for PCR amplification of
the region encompassing each SNP. To control for DNA
contamination, cDNA synthesis was performed in the
presence or absence of reverse transcriptase. PCR
products were resolved by 6% polyacrylamide gel electro-
phoresis and visualized by silver staining. Sequencing was
carried out using the BigDye Terminator v3.1 cycle
sequencing kit (Applied Biosystems), and analyzed by an
ABI PrismH 3100 genetic analyzer, following the manufac-
turer’s instructions (Applied Biosystems). At least two
independent replicates were performed for each SNP.
Results
With the purpose of reaching the DNA methylation
level similar to that achieved in DKO cells, we exposed
HCT116 cells to increasing concentrations of 5-aza-CdR.
We determined that 10 mM 5-aza-CdR for 96 h showed
levels of hypomethylation comparable to those in DKO
cells (Figure 1).
Figure 2. DNA methylation profile of CpGs (cytosine-phosphate-guanine) related to imprinted genes. A, The graph shows the DNA
methylation level of CpG sites related to imprinted genes covered in the 450K platform, arranged per chromosome (b values average
ranging from 0 to 1, unmethylated and fully methylated, respectively). Chromosomes 2, 4, and 8 presented methylation levels after 5-aza-
CdR treatment different from DNMTs disruption (DKO cells; P,0.0001).B, Global DNAmethylation level of all imprinted genes analyzed in
the different cell lines. DKO and 5-aza-29-deoxycytidine (5-aza-CdR)-treated cells exhibited statistically significant demethylation compared
to HCT116 cells.C, Schematic view of the ICR1, the imprinting center of IGF2 and H19 genes, and the range of DNA methylation level of 8
CpGs sites (ovals) analyzed in this region (cg00237904, cg06765785, cg25821896, cg25574978, cg18454954, cg25579157, cg02886509
and cg02657360). The color-ratio bar at the bottom indicates the methylation level. DKO cells DNA methylation profile was retrieved from
Gene Expression Omnibus: GSE29290, sample GSM815139. *P,0.05, Kruskal-Wallis test with Dunn’s multiple comparison post hoc test.
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DNA methylation patterns of all known imprinted human
genes were investigated using the 450K platform, where
3369 CpGs sites associated with them were queried.
HCT116 5-aza-CdR-treated cells exhibited a statistically
significant decrease in methylation levels of these sites
compared to untreated cells (Supplementary Table S2
and Figure 2A and B). Likewise, DKO cells showed a
hypomethylated pattern at imprinted genes, equivalent to
HCT116 5-aza-CdR-treated cells (Figure 2A and B).
However, the ICR of IGF2 and H19 covered by eight probes
(cg00237904, cg06765785, cg25821896, cg25574978,
cg18454954, cg25579157, cg02886509, and cg02657360)
showed a methylation pattern not significantly different
between 5-aza-CdR-treated HCT116 cells and their
untreated counterparts, but significantly different from
DKO (Figure 2C). It is worth noting that the decrease in
DNA methylation produced by 5-aza-CdR treatment or
DNMT disruption is not similar among the chromosomes. At
chromosomes 2 and 4, the 5-aza-CdR treatment leads to a
DNA hypomethylation level not reached by DNMT disruption
(P,0.0001). Conversely, chromosome 8 is less methylated
in the DKO cells than in the 5-aza-CdR-treated HCT116
cells (P,0.0001).
To evaluate the expression pattern of the 3 selected
imprinted genes (IGF2,H19, and PEG10), the HCT116 cell
line was genotyped, and at least one informative SNP
was identified in the expressed sequences of each gene
(Supplementary Table S3). These imprinted genes showed
monoallelic expression in HCT116 cells, but biallelic
expression after 5-aza-CdR treatment, even under meth-
ylation levels not statistically different at ICR1 (Figures 3
and 2C).
XIST expression was evaluated by real-time RT-PCR.
While HCT116 did not have detectable expression of XIST,
5-aza-CdR-treated HCT116 cells exhibited XIST expres-
sion, albeit approximately 25 times lower than female
fibroblasts (Figure 4A). These data are consistent with RNA
FISH analysis (Figure 4B), in which a XIST cloud was
detected in only 2 of 100 analyzed nuclei from 5-aza-CdR-
treated HCT116 cells. Despite the low XIST expression, 5-
aza-CdR-treated HCT116 cells exhibited hypomethylation
of the XIST locus (Figure 4C and Supplementary Table S4).
In contrast, DKO cells do not show significantly different
hypomethylation at the XIST locus compared to HCT116
cells, and they sustained XIST repression (Figure 4C).
Additionally, the DNA methylation profile of the X chromo-
some was analyzed using the 450K platform, and a total of
10,966 CpGs sites investigated showed that 5-aza-CdR-
treated cells were significantly less methylated than DKO
cells in that chromosome (Figure 4D and Supplementary
Table S5).
Discussion
Our aim was to verify if XIST repression is a more stable
epigenetic mark than genomic imprinting under two different
DNA hypomethylation conditions: a long-term loss of
DNMT1 and DNMT3B activity (DKO cell line) and an
acute loss of DNMT activity (HCT116-5-aza-CdR). While
HCT116-5-aza-CdR cells showed patterns of decreased
methylation at CpGs associated with XIST and imprinted
genes, DKO cells exhibited hypomethylation only in
imprinted genes. Consistent with this result, XIST is
repressed in DKO cells and is weakly expressed in
HCT116-5-aza-CdR; the imprinted genes PEG10, IGF2,
and H19 were biallelically expressed in both methylation-
deficient cell lines.
The presence of XIST expression from the only X
chromosome in the 5-aza-CdR-treated HCT116 cell line
was previously reported by our group (14). Here, we
extended this analysis showing that XIST was activated
in only a few HCT116-5-aza-CdR cells, despite the XIST
gene being hypomethylated. These findings may indicate
that other epigenetic marks, such as histone modifica-
tions, are repressing XIST in this short-term assay (20).
However, hypomethylated HCT116 cells in culture for
long periods (DKO cells) showed DNA methylation levels
at the XIST locus similar to untreated HCT116 cells,
suggesting that DNMTs other than DNMT1 and DNMT3B
might be responsible for XIST repression in DKO cells.
Accordingly, there is evidence that Dnmt3a is responsible
for both inactivation and maintenance of Xist repression
Figure 3. Expression pattern of the selected imprinted genes in
the HCT116 cell line after 5-aza-29-deoxycytidine (5-aza-CdR)
treatment. Electropherograms of cDNA sequences of PEG10,
H19 and IGF2 genes show the biallelic expression. Symbols of
genes and corresponding single nucleotide polymorphism (SNP)
ID are indicated at the side. SNP positions are highlighted in
yellow.
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in murine ES cells and that it may help to keep global DNA
methylation (21-23). Therefore, the absence of XIST
expression in DKO cells might be due to the presence of
DNMT3A.
In contrast, despite the importance of DNMT3A for the
establishment of genomic imprinting during gametogenesis
(24), this enzyme is not sufficient to keep monoallelic
expression of imprinted genes, since DKO cells showed
hypomethylation at imprinted genes and loss of imprinting
(LOI). Whereas XIST expression and the consequent XCI
could lead to the death of male cells, LOI may provide an
advantage during cell proliferation, because it is a common
feature in many types of cancer (25). Supporting this idea,
biallelic expression of the imprinted genes PEG10, IGF2,
and H19 in the HCT116 cell line treated with 5-aza-CdR is
also seen in DKO cells, even without any significant decrease
in methylation of ICR1. Additionally, there is widespread
hypomethylation in several CpG sites related to imprinted
genes in DKO cells and in HCT116 after 5-aza-CdR
exposure; thus, it is possible that other imprinted genes also
show biallelic expression in HCT116 hypomethylated cells.
Therefore, our data suggest that XIST repression is
more tightly controlled than the allele-specific expression
of imprinted genes in a long-term loss of global DNA
methylation. It is not known whether there is specific
machinery for XIST repression or whether there is only cell
selection against XIST-expressing cells; however, the
control of XIST expression is more important for cell survival
than the control of genomic imprinting. Nonetheless, our
data indicate that DNMT3A might be responsible for XIST
silencing in DKO cells, since DNA methylation levels are
increased at the XIST locus in these cells, despite the
absence of any other known active DNA methyltransferase.
It is interesting to note that chromosomes 2, 4, and X are
more methylated in DKO cells compared to 5-aza-CdR-
treated HCT116 cells, suggesting that DNMT3A is involved
in the repression of other genes in those chromosomes that
may be important for long-term cell survival in culture.
Additionally, 5-aza-CdR treatment induces other effects
than DNA hypomethylation. This drug is able to reduce the
levels of G9A protein, decreasing H3K9me2, and resulting
in gene activation (26). Also, 5-aza-CdR exposure can lead
Figure 4. XIST expression. A, Relative expression levels of XIST RNA in HCT116 and a female cell line. The expression of YWAHZ
was used as a reference. B, XIST RNA FISH in female cell line (i) and male HCT116 cell line treated with 10 mM 5-aza-CdR (5-aza-29-
deoxycytidine) for 96 h (ii). Nuclei were counterstained with DAPI (blue) and XIST RNA signals are red. The scale bar corresponds to
10 mm. C, XIST DNA methylation pattern by 8 CpGs (cytosine-phosphate-guanine) sites of 450K platform (cg15319295, cg12653510,
cg05533223, cg117117280, cg20698282, cg17513789, cg02644889, and cg17279685). The color-ratio bar at the bottom indicates the
methylation level. D, DNA methylation level of CpG sites related to X chromosome covered in the 450K platform; **P,0.0001, Kruskal-
Wallis test with Dunn’s multiple comparison post hoc test.
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to activation of the DNA damage response pathway,
allowing pRb pocket protein degradation and a decrease
in repressive posttranslational histone modifications (27).
Thus, these additional effects of 5-aza-CdR can contribute
to divergences in gene expression compared with DKO
cells.
Finally, it is important to mention that these phenom-
ena can occur in different ways in normal cells. Cancer
cells have epigenomes very different from normal cells
(28), making them susceptible to modifying agents of
epigenetic marks, as demonstrated in several studies (29-
33). Additional analyses will be important for comparing
the maintenance of epigenetic controls associated with
XCI and genomic imprinting in normal and transformed
human cells.
Supplementary Material
Click here to view [pdf].
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